...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2018

AACR 2018 Cancer Meeting coming up in April 2018. Abstract submission deadlines coming up fast! I wonder if Zenith will submit anything?

Clinical Trials Abstract Submission Deadline: Tuesday, Jan. 23, 2018 at 11:59 p.m. U.S. ET

Late-Breaking Abstract Submission Deadline: Tuesday, Jan. 23, 2018 at 11:59 p.m. U.S. ET

Share
New Message
Please login to post a reply